Glymphatic dysfunction, plasma neurofilament light, and cortical free water mediate cognitive decline in familial frontotemporal lobar degeneration - 05/07/26

Doi : 10.1016/j.tjpad.2026.100639 
Meiling Qiu a, b, 1, Li Ding a, b, 1, Rui Bao a, c, 1, Juanyu Gong a, c, Wencai Ding a, c, , Zhiding Shao a, c, , Yongsheng Han a,
for the

ARTFL-LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD) Research Consortium 1

  These authors contributed equally to this work.

a Wannan Medical University, Wuhu, 241000, China 
b The First Affiliated Hospital of Wannan Medical University, Wuhu, 241000, China 
c The Second Affiliated Hospital of Wannan Medical University, Wuhu, 241000, China 

Corresponding authors at: Wannan Medical University, Wuhu, 241000, China. Wannan Medical University Wuhu 241000 China ⁎⁎ Corresponding authors at: The Second Affiliated Hospital of Wannan Medical University, Wuhu, 241000, China. The Second Affiliated Hospital of Wannan Medical University Wuhu 241000 China

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.

Conéctese para beneficiarse!

Abstract

Background

Familial frontotemporal lobar degeneration (f-FTLD) is the second most common form of young-onset dementia, with diverse clinical presentations, neuropathological substrates and genetic backgrounds. While evidence suggests that glymphatic dysfunction, neuroaxonal injury, and cortical microstructural alterations may jointly contribute to f-FTLD, their interrelationships across genotypes remain unclear.

Objectives

This study aims to investigate the roles of glymphatic dysfunction, cortical free water (cFW), and plasma neurofilament light (NfL) in f-FTLD and examine their relationship with cognitive decline.

Design

A multimodal approach was applied, involving diffusion tensor imaging along the perivascular space (DTI-ALPS) for glymphatic function, plasma NfL measurement, and voxel-wise cortical free water mapping. Analyses comparing FTLD mutation groups and serial mediation analyses were conducted in 322 participants ( C9orf72, GRN, MAPT mutation carriers, and matched controls).

Setting

This study was conducted across multiple participating centers using standardized imaging protocols and harmonized multi-site data.

Participants

A total of 322 participants were included: 87 C9orf72 expansion carriers, 56 GRN mutation carriers, 58 MAPT mutation carriers, and 121 healthy controls.

Intervention

No intervention was applied in this observational study. Participants underwent genetic testing, cognitive assessment, and diffusion MRI scans; plasma NfL was available for mutation carriers.

Measurements

Glymphatic function was assessed using DTI-ALPS, plasma NfL levels were measured to reflect neuroaxonal injury, and cortical microstructure was assessed through cortical free water (cFW) mapping.

Results

Significant reductions in DTI-ALPS and elevations in cFW were observed in C9orf72 and GRN mutation carriers, with strong associations to clinical cognitive decline. Plasma NfL levels were highest in GRN mutation carriers and correlated strongly with cognitive severity. Mediation analysis indicated that the pathway linking DTI-ALPS to cognition through NfL explained a substantial portion of the indirect effect, while residual direct effects suggested that additional mechanisms also contribute to cognitive decline.

Conclusions

This study identifies glymphatic dysfunction as a key factor contributing to cognitive decline in f-FTLD, with plasma NfL serving as an important partial mediator and cFW providing additional region-specific information.

El texto completo de este artículo está disponible en PDF.

Keywords : f-FTLD, Glymphatic system, DTI-ALPS, Cortical free water, NfL


Esquema


© 2026  The Authors. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 13 - N° 8

Artículo 100639- octobre 2026 Regresar al número
Artículo precedente Artículo precedente
  • Tau-ing and fro-ing: the tanycytic shuttle in neurodegeneration
  • Vincent Prévot, Markus Schwaninger, Ruben Nogueiras, S. Rasika
| Artículo siguiente Artículo siguiente
  • Dietary patterns and Alzheimer's disease: East-west perspectives and future intervention strategies
  • Wanlu Jiang, Yijia Lin, Qihao Guo, Ya Miao

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.